BIOGEN INC (IDP.DE) Stock Analyst Ratings
Europe - FRA:IDP - US09062X1037 - Common Stock
133 EUR
-1.45 (-1.08%)
ChartMill assigns a Buy % Consensus number of 74% to IDP.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 150.4. This target is 13.09% above the current price.
IDP.DE was analyzed by 42 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about IDP.DE.
In the previous month the buy percentage consensus was at a similar level.
IDP.DE was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-02 | Mizuho | Maintains | Neutral |
| 2021-07-27 | Canaccord Genuity | Maintains | Buy |
| 2021-07-23 | RBC Capital | Maintains | Sector Perform |
| 2021-07-23 | Morgan Stanley | Maintains | Overweight |
| 2021-07-16 | Morgan Stanley | Maintains | Overweight |
| 2021-06-28 | RBC Capital | Maintains | Sector Perform |
| 2021-06-18 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-06-14 | Truist Securities | Maintains | Buy |
| 2021-06-14 | Goldman Sachs | Maintains | Neutral |
| 2021-06-11 | Bernstein | Upgrade | Market Perform -> Outperform |
| 2021-06-10 | UBS | Upgrade | Neutral -> Buy |
| 2021-06-10 | SVB Leerink | Maintains | Outperform |
| 2021-06-08 | William Blair | Upgrade | Market Perform -> Outperform |
| 2021-06-08 | RBC Capital | Maintains | Sector Perform |
| 2021-06-08 | Barclays | Maintains | Equal-Weight |
| 2021-06-08 | Baird | Upgrade | Underperform -> Neutral |
| 2021-06-08 | Morgan Stanley | Maintains | Overweight |
| 2021-06-08 | Citigroup | Upgrade | Sell -> Neutral |
| 2021-06-08 | Jefferies | Maintains | Buy |
| 2021-06-08 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-18 | Oppenheimer | Maintains | Outperform |
| 2021-04-19 | Morgan Stanley | Maintains | Overweight |
| 2021-04-12 | Wedbush | Maintains | Neutral |
| 2021-02-17 | Cantor Fitzgerald | Maintains | Neutral |
BIOGEN INC / IDP.DE FAQ
What is the average price target for BIOGEN INC (IDP.DE) stock?
42 analysts have analysed IDP.DE and the average price target is 150.4 EUR. This implies a price increase of 13.08% is expected in the next year compared to the current price of 133.
How do analysts rate BIOGEN INC (IDP.DE)?
The consensus rating for BIOGEN INC (IDP.DE) is 73.8095 / 100 . This indicates that analysts generally have a positive outlook on the stock.